Your browser doesn't support javascript.
loading
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell.
Kildisiute, Gerda; Kholosy, Waleed M; Young, Matthew D; Roberts, Kenny; Elmentaite, Rasa; van Hooff, Sander R; Pacyna, Clarissa N; Khabirova, Eleonora; Piapi, Alice; Thevanesan, Christine; Bugallo-Blanco, Eva; Burke, Christina; Mamanova, Lira; Keller, Kaylee M; Langenberg-Ververgaert, Karin P S; Lijnzaad, Philip; Margaritis, Thanasis; Holstege, Frank C P; Tas, Michelle L; Wijnen, Marc H W A; van Noesel, Max M; Del Valle, Ignacio; Barone, Giuseppe; van der Linden, Reinier; Duncan, Catriona; Anderson, John; Achermann, John C; Haniffa, Muzlifah; Teichmann, Sarah A; Rampling, Dyanne; Sebire, Neil J; He, Xiaoling; de Krijger, Ronald R; Barker, Roger A; Meyer, Kerstin B; Bayraktar, Omer; Straathof, Karin; Molenaar, Jan J; Behjati, Sam.
Afiliação
  • Kildisiute G; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • Kholosy WM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Young MD; Wellcome Sanger Institute, CB10 1SA Hinxton, UK. my4@sanger.ac.uk k.straathof@ucl.ac.uk j.j.molenaar@prinsesmaximacentrum.nl sb31@sanger.ac.uk.
  • Roberts K; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • Elmentaite R; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • van Hooff SR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Pacyna CN; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • Khabirova E; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • Piapi A; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
  • Thevanesan C; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
  • Bugallo-Blanco E; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
  • Burke C; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
  • Mamanova L; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • Keller KM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Langenberg-Ververgaert KPS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Margaritis T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Holstege FCP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Tas ML; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • van Noesel MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Del Valle I; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
  • Barone G; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK.
  • van der Linden R; Hubrecht Institute, KNAW, 3584 CT Utrecht, Netherlands.
  • Duncan C; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK.
  • Anderson J; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
  • Achermann JC; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK.
  • Haniffa M; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
  • Teichmann SA; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • Rampling D; Institute of Cellular Medicine, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Sebire NJ; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals, NHS Foundation Trust, NE2 4LP Newcastle upon Tyne, UK.
  • He X; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.
  • de Krijger RR; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK.
  • Barker RA; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK.
  • Meyer KB; MRC-WT Cambridge Stem Cell Institute, University of Cambridge, CB2 0QQ Cambridge, UK.
  • Bayraktar O; Department of Clinical Neurosciences, University of Cambridge, CB2 0QQ Cambridge, UK.
  • Straathof K; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.
  • Molenaar JJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands.
  • Behjati S; MRC-WT Cambridge Stem Cell Institute, University of Cambridge, CB2 0QQ Cambridge, UK.
Sci Adv ; 7(6)2021 02.
Article em En | MEDLINE | ID: mdl-33547074
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neurais / Neuroblastoma Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neurais / Neuroblastoma Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article